BioCentury | Dec 22, 2020
Regulation

Dec. 21-23 Regulatory Quick Takes: positive CHMP opinion for Pfizer-BioNTech COVID-19 vaccine; plus Urovant’s approval, a Feb. 9 adcomm for Keytruda in TNBC, NMPA reviewing a subcutaneous PD-L1, and more

...clinical testing.European approval for Orchard’s leukodystrophy therapyOrchard Therapeutics Inc. (NASDAQ:ORTX) and partners Fondazione Telethon and Ospedale San Raffaele...
BioCentury | Apr 20, 2020
Finance

French VC Sofinnova expanding start-up ecosystem in Italy with new local fund’s first investments

...those partners, Lucia Faccio and Paola Pozzi, have previously led the tech transfer office of Ospedale San Raffaele...
...lavorare : We keep our head down and we continue to work.” Paul Bonanos, Associate Editor Fondazione Telethon Ospedale San Raffaele Sofinnova...
BioCentury | May 28, 2019
Company News

May 28 Company Quick Takes: Viela finds China partner for rare CNS disorder mAb; plus Santhera, Juvenescence’s Souvien and more

...well as schizophrenia. Orchard gets rights to MPS-I gene therapy Fondazione Telethon (Milan, Italy) and Ospedale San Raffaele...
...cariprazine (Generic) Allergan plc Celgene Corp. Fondazione Telethon Gedeon Richter plc Hansoh Pharmaceutical Group Co. Ltd. Juvenescence Ltd. Newron Pharmaceuticals S.p.A. Orchard Therapeutics plc Ospedale San Raffaele Santhera...
BioCentury | Apr 13, 2018
Company News

Orchard gains GSK's rare disease gene therapy portfolio

...to treat beta-thalassemia. It also will acquire options to exclusively license from Fondazione Telethon and Ospedale San Raffaele...
BioCentury | Apr 12, 2018
Company News

Orchard gains GSK's rare disease gene therapy portfolio

...to treat beta-thalassemia. It also will acquire options to exclusively license from Fondazione Telethon and Ospedale San Raffaele...
BioCentury | Oct 27, 2017
Company News

NICE recommends GSK's Strimvelis for ADA-SCID

...ADA-SCID affects about 15 patients per year in Europe, and GSK makes Strimvelis available at Ospedale San Raffaele...
...guidance is expected in February 2018. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Endocrine/Metabolic Mary Romeo GSK2696273 Strimvelis GlaxoSmithKline plc Ospedale San Raffaele...
BioCentury | Oct 22, 2017
Company News

NICE recommends Strimvelis for ADA-SCID

...ADA-SCID affects about 15 patients per year in Europe, and GSK makes Strimvelis available at Ospedale San Raffaele...
...is accepting public comments until Nov. 13. Final guidance is expected in February 2018. Mary Romeo Strimvelis GlaxoSmithKline plc Ospedale San Raffaele Adenosine...
BioCentury | Oct 11, 2017
Preclinical News

Researchers optimize gene editing for SCID

...Researchers from Ospedale San Raffaele and elsewhere used zinc finger nuclease and CRISPR- Cas9 (CRISPR-associated protein 9)-based gene...
...on the technology described in the paper. Mark Zipkin Bayer AG CRISPR Therapeutics AG Genenta Science s.r.l. Magenta Therapeutics Inc. MolMed S.p.A. Ospedale San Raffaele Sangamo...
BioCentury | Jan 13, 2017
Emerging Company Profile

Conditional replication

...second IND ready to file for a to-be-determined indication. Oncorus licensed IP from Pitt and Ospedale San Raffaele...
...cancer Companies and Institutions Mentioned Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Oncorus Inc., Cambridge, Mass. Ospedale San Raffaele...
BioCentury | Sep 26, 2016
Company News

Genenta Science, Amgen, Ospedale San Raffaele deal

...to provide details. Genenta Science s.r.l. , Milan, Italy Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Ospedale San Raffaele...
Items per page:
1 - 10 of 21
BioCentury | Dec 22, 2020
Regulation

Dec. 21-23 Regulatory Quick Takes: positive CHMP opinion for Pfizer-BioNTech COVID-19 vaccine; plus Urovant’s approval, a Feb. 9 adcomm for Keytruda in TNBC, NMPA reviewing a subcutaneous PD-L1, and more

...clinical testing.European approval for Orchard’s leukodystrophy therapyOrchard Therapeutics Inc. (NASDAQ:ORTX) and partners Fondazione Telethon and Ospedale San Raffaele...
BioCentury | Apr 20, 2020
Finance

French VC Sofinnova expanding start-up ecosystem in Italy with new local fund’s first investments

...those partners, Lucia Faccio and Paola Pozzi, have previously led the tech transfer office of Ospedale San Raffaele...
...lavorare : We keep our head down and we continue to work.” Paul Bonanos, Associate Editor Fondazione Telethon Ospedale San Raffaele Sofinnova...
BioCentury | May 28, 2019
Company News

May 28 Company Quick Takes: Viela finds China partner for rare CNS disorder mAb; plus Santhera, Juvenescence’s Souvien and more

...well as schizophrenia. Orchard gets rights to MPS-I gene therapy Fondazione Telethon (Milan, Italy) and Ospedale San Raffaele...
...cariprazine (Generic) Allergan plc Celgene Corp. Fondazione Telethon Gedeon Richter plc Hansoh Pharmaceutical Group Co. Ltd. Juvenescence Ltd. Newron Pharmaceuticals S.p.A. Orchard Therapeutics plc Ospedale San Raffaele Santhera...
BioCentury | Apr 13, 2018
Company News

Orchard gains GSK's rare disease gene therapy portfolio

...to treat beta-thalassemia. It also will acquire options to exclusively license from Fondazione Telethon and Ospedale San Raffaele...
BioCentury | Apr 12, 2018
Company News

Orchard gains GSK's rare disease gene therapy portfolio

...to treat beta-thalassemia. It also will acquire options to exclusively license from Fondazione Telethon and Ospedale San Raffaele...
BioCentury | Oct 27, 2017
Company News

NICE recommends GSK's Strimvelis for ADA-SCID

...ADA-SCID affects about 15 patients per year in Europe, and GSK makes Strimvelis available at Ospedale San Raffaele...
...guidance is expected in February 2018. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Endocrine/Metabolic Mary Romeo GSK2696273 Strimvelis GlaxoSmithKline plc Ospedale San Raffaele...
BioCentury | Oct 22, 2017
Company News

NICE recommends Strimvelis for ADA-SCID

...ADA-SCID affects about 15 patients per year in Europe, and GSK makes Strimvelis available at Ospedale San Raffaele...
...is accepting public comments until Nov. 13. Final guidance is expected in February 2018. Mary Romeo Strimvelis GlaxoSmithKline plc Ospedale San Raffaele Adenosine...
BioCentury | Oct 11, 2017
Preclinical News

Researchers optimize gene editing for SCID

...Researchers from Ospedale San Raffaele and elsewhere used zinc finger nuclease and CRISPR- Cas9 (CRISPR-associated protein 9)-based gene...
...on the technology described in the paper. Mark Zipkin Bayer AG CRISPR Therapeutics AG Genenta Science s.r.l. Magenta Therapeutics Inc. MolMed S.p.A. Ospedale San Raffaele Sangamo...
BioCentury | Jan 13, 2017
Emerging Company Profile

Conditional replication

...second IND ready to file for a to-be-determined indication. Oncorus licensed IP from Pitt and Ospedale San Raffaele...
...cancer Companies and Institutions Mentioned Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Oncorus Inc., Cambridge, Mass. Ospedale San Raffaele...
BioCentury | Sep 26, 2016
Company News

Genenta Science, Amgen, Ospedale San Raffaele deal

...to provide details. Genenta Science s.r.l. , Milan, Italy Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Ospedale San Raffaele...
Items per page:
1 - 10 of 21